Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments

The safety and persistence of non-vitamin-K-antagonist oral anticoagulants in atrial fibrillation patients treated in a well structured atrial fibrillation clinic

(2016) Faris Al-Khalili et al.   CURRENT MEDICAL RESEARCH AND OPINION

Minimizing the Risk of Bleeding with NOACs in the Elderly

(2016) Amartya Kundu et al.   DRUGS & AGING

Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary

(2016) Hein Heidbuchel et al.   EUROPEAN HEART JOURNAL

Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study

(2016) Martin H. Ellis et al.   European Journal of Internal Medicine

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

(2016) A John Camm et al.   HEART

Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes

(2016) Benjamin A. Steinberg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

(2016) C. Michael Gibson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC

(2016) Anja Katholing et al.   THROMBOSIS AND HAEMOSTASIS

Overview of the New Oral Anticoagulants: Opportunities and Challenges

(2015) C. H. Yeh et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study

(2015) A. Gorst-Rasmussen et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Estimation of dabigatran plasma concentrations in the perioperative setting

(2015) Anne-Sophie Dincq et al.   THROMBOSIS AND HAEMOSTASIS

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

(2014) et al.   EUROPEAN HEART JOURNAL

Clinical challenges related to novel oral anticoagulants: drug-drug interactions and monitoring

(2014) R. Altena et al.   HAEMATOLOGICA

Using focus groups in medical education research: AMEE Guide No. 91

(2014) Renée E. Stalmeijer et al.   MEDICAL TEACHER

Dabigatran, bleeding, and the regulators

(2014) T. J. Moore et al.   BMJ-British Medical Journal

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

(2013) J. H. Alexander et al.   EUROPEAN HEART JOURNAL

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

(2013) Amanda R. Harrington et al.   STROKE

Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

(2012) Antonio L. Dans et al.   CIRCULATION

Hospital physicians’ assessments of their interaction with GPs: The role of physician and community characteristics

(2012) Pål E. Martinussen   HEALTH POLICY

Non-adherence to new oral anticoagulants: a reason for concern during long-term anticoagulation?

(2012) R. A. RODRIGUEZ et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

General practitioners’ reflections on referring: An asymmetric or non-dialogical process?

(2012) Olav Thorsen et al.   SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE

Systematic text condensation: A strategy for qualitative analysis

(2012) Kirsti Malterud   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Accurate determination of rivaroxaban levels requires different calibrator sets but not addition of antithrombin

(2012) Gabriele Rohde et al.   THROMBOSIS AND HAEMOSTASIS

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE